Key Slides on Assessing Virologic Failure in Heavily Treatment–Experienced Patients With HIV

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure for patients with multiclass drug resistance.
Princy N. Kumar, MD, FIDSA, MACP
Brian Wood, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 310 KB
Released: February 22, 2021


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Educational grant provided by:
ViiV Healthcare

Related Content

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Slides from Daniel Kuritzkes and CCO. Switching to long-acting cabotegravir: ATLAS and FLAIR data, starting, dosing regimens, avoiding treatment failure

Daniel R. Kuritzkes, MD Released: June 4, 2021

Drs Roger Bedimo, Princy N. Kumar, and Brian Wood, answer commonly asked questions on managing heavily treatment-experienced patients with HIV

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

Free expert slides from Clinical Care Options (CCO) reviewing the use of HIV-ASSIST to guide ART in a treatment-experienced patient with comorbidities

Ethel D. Weld, MD, PhD Released: May 27, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.